Dyadic International, Inc. (DYAI) Stock Analysis

Company Overview

The market values Dyadic International, Inc. (DYAI) at $16.03M. It is classified in the Biotechnology industry, within the Healthcare sector. The company reports 5 employees.

The most recent close on file for DYAI is $0.40, dated October 21, 2026. That is +$0.01 (+3.87%) against the previous close. Over the past 52 weeks the price has ranged from $0.34 to $1.60. The latest close sits 17.65% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $1.23M. Against the prior fiscal year total of $3.50M, that is a change of −64.74%. The same year closed with a net loss of $7.36M. Profit margin runs at −200.46%. That is 162.1 percentage points below the Biotechnology median of −38.31%. Earnings per share on a trailing basis come to −0.23.

Across the 4 fiscal years on file, revenue moves from $2.93M in 2022 to $1.23M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 4.21 times revenue. On price-to-sales that is 0.3 times the Biotechnology median of 13.3. 608 Biotechnology companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at 0.96. Daily returns over the trailing 10 years annualize to a volatility of 72.03%. Over the trailing twelve months the total return is −63.96%. Measured over 10 years, that is −13.16% a year compounded.

Growth & Income

The record shows no dividend for DYAI.

2026 is still running; the total return is −57.45% year to date. The strongest complete calendar year on file is 2019 at +174.07%; the weakest is 2022 at −72.79%. Of the 9 complete calendar years on file, 5 finished higher.